Cargando…
CAR-T Cell Therapy: Mechanism, Management, and Mitigation of Inflammatory Toxicities
Engineered T cell therapies such as chimeric antigen receptor (CAR) expressing T cells (CAR-T cells) have great potential to treat many human diseases; however, inflammatory toxicities associated with these therapies present safety risks and can greatly limit its widespread use. This article briefly...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250150/ https://www.ncbi.nlm.nih.gov/pubmed/34220853 http://dx.doi.org/10.3389/fimmu.2021.693016 |